Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment-Analyses from the German clinical RCC-Registry. 26. Juli 2018 Goebell, P.J., Müller, L., Hübner, A., Harich, H.-D., Boller, E., Koska, M., Jänicke, M., Marschner, N., RCC-Registry Group (Tumour Registry of Advanced Renal Cell Carcinoma), 2018. Urol. Oncol. 36, 470.e1-470.e9. https://doi.org/10.1016/j.urolonc.2018.07.007 Abstract Impact of performance status and transfusion dependency on outcome of patients with myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia treated with azacitidine (PIAZA study). Wehmeyer, J., Zaiss, M., Losem, C., Schmitz, S., Niemeier, B., Harde, J., Hannig, C.V., Harich, H.-D., Müller, J., Klausmann, M., Tessen, H.W., Potthoff, K., 2018. Weiterlesen Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma – Analyses From the German Clinical RCC-Registry. Goebell, P.J., Staehler, M., Müller, L., Nusch, A., Scheffler, M., Sauer, A., von Verschuer, U., Tech, S., Kruggel, L., Jänicke, M., Marschner, N., RCC-Registry Group… Weiterlesen